Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| ZIAHG200366 | Germline modifiers of tumor progression and metastasis in prostate cancer | 1 | 2016 |
| R01CA152327 | Tumor Penetrating Peptides for Cancer Targeting | 6 | 2015 |
| R01CA151245 | The molecular basis of RECQ4-associated genetic disorders and cancer predispositi | 2 | 2015 |
| R21AI109464 | Inhibition of Ebolavirus Entry by IFITM2 Protein | 2 | 2015 |
| K08AR060257 | Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis | 1 | 2015 |
| K22AI100935 | Innate immune regulation during hepatitis C virus infection | 1 | 2015 |
| KL2TR000119 | Heartland Institute for Clinical and Translational Research | 1 | 2015 |
| P50CA086355 | Center for Molecular Imaging Research at MGH/HMS | 1 | 2015 |
| R00CA160350 | Nanoparticle Co-delivery of RNAi and Chemotherapy for Multidrug Resistant Cancers | 1 | 2015 |
| R00CA166527 | Mechanistic Roles of Long mcRNA-regulated Gene Transcription in Prostate Cancer | 1 | 2015 |
| R00DK094981 | Nuclear Architecture, NcRNAs and Epigenetics in Transcriptional Regulation by ER | 1 | 2015 |
| R00HD071011 | Epigenetic Regulation of Drosophila Germline Development | 1 | 2015 |
| R01AI034431 | Outer Membrane Proteins of Pathogenic Leptospira Species | 1 | 2015 |
| R01AI043894 | HIV-1 Inhibition Using Tat peptide derivatives | 1 | 2015 |
| R01AI059536 | Ebola virus VP24_a novel inhibitor of interferon and oxidative stress signaling | 1 | 2015 |
| R01AI061580 | Regulation of RNA editing in Trypanosoma brucei | 1 | 2015 |
| R01AI091526 | Synergistic effect of HIV virions and bacterial LPS on memory B cell apoptosis | 1 | 2015 |
| R01AI091786 | The Role of IFITM3 in the Anti-viral Host Response | 1 | 2015 |
| R01CA037393 | Modulators of Prostate Cancer Metastasis | 1 | 2015 |
| R01CA088763 | LANA and Cellular Gene Expression | 1 | 2015 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=39